Asahi Kasei’s Hovilpri is now approved for treating lesions caused by herpes simplex virus infection. This daily pill came from the $919 million acquisition of AiCuris Anti-Infective Cures. The post Asahi Kasei Acquisition Pays Off With FDA Approval for Novel Herpes Drug appeared first on MedCity News.

Outro’s funding included participation from Listen Ventures, Cake Ventures, Jason Calicanis’s LAUNCH, Actions Capital, Hannah Grey Ventures, SemperVirens, Brock Recovery Group and Pave Health Ventures. The post Outro Raises $7M To Support Safe Deprescribing appeared first on MedCity News.

Investing in pediatric care is not simply a moral imperative. It is one of the most practical long-term investments the healthcare system can make. The post Pediatric Innovation Isn’t a Small-Market Problem, It’s an Incentive Problem appeared first on MedCity News.

Asking the right questions about community support, caregiving responsibilities, emotional well-being, and the availability of trusted social networks can establish important context for a person’s outcomes — and spark conversations about social needs that might never otherwise take place. The post Loneliness And Diabetes: Harnessing an Opportunity for Better Outcomes appeared first on MedCity News.

Register for INVEST Digital Health, scheduled for October 29 in Dallas, for an engaging discussion on the impact of consumer-centered care from diagnostics to employer benefits and more. The post Join Us at INVEST Digital Health for a Conversation on Consumer-Centered Care across the Healthcare Ecosystem appeared first on MedCity News.

The FDA recently published draft guidance on pre-market testing for robotically-assisted surgical devices, raising timely discussion around whether hospital infrastructures are capable of supporting increasingly complex systems.  The post Are Hospital Operating Rooms Ready For FDA’s Expectations for Surgical Robots? appeared first on MedCity News.

Eli Lilly-partnered TRexBio will apply the IPO proceeds toward clinical development of molecules designed to activate regulatory T cells to mediate immune responses and inflammation. Meanwhile, Retension Pharmaceuticals will use its IPO cash for mid-stage testing of a next-generation hypertension drug. The post TRrexBio’s IPO Bags $116M to Bring the Immune System Back Into Balance appeared first on MedCity News.

The pace of change in digital innovation has exposed the ever-widening gap between digital health and Pharma commercial teams. As a result, Pharma is missing out on its ability to significantly improve its commercial model, by focusing on efficiencies vs. truly reinventing. The post What Life Sciences Commercial Teams Can Learn from Digital Health appeared first on MedCity News.

Diagnostics and drug development startup Arboretum LifeSciences launched with $30 million in financing. Its executives say analyses of data from its genetic tests both form the basis of partnerships with big pharma and lead to the formation of new biotech companies — all focused on common diseases. The post Startup Arboretum Sprouts, Bringing a Precision Medicine Approach to Common Diseases appeared first on MedCity News.

The Series A round was led by Oak HC/FT, with participation from Norwest, .406 Ventures, Constellation Ventures, Y Combinator, Rock Health Capital and MemorialCare Innovation Fund.  The post Vitalize Secures $31M To Help Hospitals Manage Labor, Capacity appeared first on MedCity News.

Earlier detection is valuable, but it creates a duty that does not end when an alert appears in the electronic health record. Health systems need to decide, in advance, how a risk signal becomes a clinically accountable pathway. The post AI Can Flag Cognitive Decline Earlier — Health Systems Still Own What Happens Next appeared first on MedCity News.

Trilliant Health’s report identifies six trends highlighting how misaligned incentives are contributing to rising costs, poor health outcomes, workforce shortages and other systemic problems in U.S. healthcare. The post Trilliant Health: Misaligned Incentives Are Undermining US Healthcare appeared first on MedCity News.

Teladoc Health announced Wednesday that it is launching two new AI-powered capabilities built into its Solo smart care platform for hospitals and health systems to be used during virtual visits. The post Teladoc Health Adds Contactless Vitals and Ambient AI Scribe to Virtual Visit Platform appeared first on MedCity News.

Caribou Biosciences is stopping work on its two remaining cancer cell therapies and exploring strategic alternatives for the business. The move follows the CRISPR biotech company’s failure to secure financing for its clinical trial plans. The post Caribou Bio’s Journey With Off-the-Shelf Cell Therapy Reaches the End of the Road appeared first on MedCity News.

[Sponsored] Sponsored by Cotiviti, a webinar addressing the challenges of AI implementation and governance offered insights based on findings from the Healthcare AI Readiness Index. The post Constant Vigilance is the Watchword for Healthcare AI Governance  appeared first on MedCity News.